<?xml version="1.0" encoding="UTF-8"?>
<STUDY_SET xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <STUDY accession="ERP019493" alias="scDNA_seq_test_31Oct16-sc-4466" center_name="Wellcome Sanger Institute">
    <IDENTIFIERS>
      <PRIMARY_ID>ERP019493</PRIMARY_ID>
      <EXTERNAL_ID namespace="BioProject">PRJEB17625</EXTERNAL_ID>
      <SUBMITTER_ID namespace="SC">scDNA_seq_test_31Oct16-sc-4466</SUBMITTER_ID>
      <SUBMITTER_ID namespace="Wellcome Sanger Institute">scDNA_seq_test_31Oct16-sc-4466</SUBMITTER_ID>
    </IDENTIFIERS>
    <DESCRIPTOR>
      <STUDY_TITLE>scDNA_seq_test_31Oct16</STUDY_TITLE>
      <STUDY_TYPE existing_study_type="Whole Genome Sequencing"/>
      <STUDY_ABSTRACT>This is a preliminary sequencing run using a MiSeq nano flow cell and 2x25 bp sequencing of a human DNA library made from 22 pg bulk DNA, processed using CEL's novel scDNA-seq protocol. Its sole purpose is to test the sequencability of the library, look for possible contaminants reads, and to ensure that the library is structured to include the expected UMIs and fragmentation coordinates near restriction sites.</STUDY_ABSTRACT>
      <STUDY_DESCRIPTION>This is a preliminary sequencing run using a MiSeq nano flow cell and 2x25 bp sequencing of a human DNA library made from 22 pg bulk DNA, processed using CEL's novel scDNA-seq protocol. Its sole purpose is to test the sequencability of the library, look for possible contaminants reads, and to ensure that the library is structured to include the expected UMIs and fragmentation coordinates near restriction sites.</STUDY_DESCRIPTION>
    </DESCRIPTOR>
    <STUDY_ATTRIBUTES>
      <STUDY_ATTRIBUTE>
        <TAG>ENA-FIRST-PUBLIC</TAG>
        <VALUE>2019-01-08</VALUE>
      </STUDY_ATTRIBUTE>
      <STUDY_ATTRIBUTE>
        <TAG>ENA-LAST-UPDATE</TAG>
        <VALUE>2016-11-02</VALUE>
      </STUDY_ATTRIBUTE>
    </STUDY_ATTRIBUTES>
  </STUDY>
</STUDY_SET>
